Sign In
Buy SDGR
$15.14
-0.210 (-1.37%)
At Close: Jul 31, 2026
Schrödinger Hosts First Annual Educator's Day and Announces “Teaching with Schrödinger” Program
08:01am, Wednesday, 28'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will host its first annual Educator's Day and "Teaching with Schrödinger" Program.
Schrödinger to Present at Two Virtual Investor Conferences in July
08:01am, Wednesday, 14'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will present at two investor conferences in July.
Schrodinger: Competitive Advantages Galore
12:10pm, Wednesday, 07'th Jul 2021
Schrodinger is a computational, physics-based molecule discovery platform that is looking to improve human health and quality of life. They are trying to do this by optimizing and transforming the way
The 1 Stock I'd Buy Right Now
05:49am, Saturday, 03'rd Jul 2021
I'm confident that Schrodinger will be a 10-bagger over the next decade. And it might go up a lot more than that.
My Favorite Biotech Stock Right Now
12:00pm, Sunday, 27'th Jun 2021
I'm an owner of Schrodinger because this company's software is revolutionizing drug discovery, and it's going to be a monster stock over the next decade.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Thursday, 17'th Jun 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).
7 Stocks To Buy if You're Trying to Double Your Money in 2021
05:01am, Tuesday, 15'th Jun 2021
Searching for stocks to buy that could legitimately double before 2022? These seven are in position to do just that.
5 Healthcare Stocks to Buy for Their Game-Changing Potential
11:37am, Tuesday, 08'th Jun 2021
These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies. The post 5 Healthcare Stocks to Buy for Their Game-Changing Potential
Schrodinger: High Margins, Sticky Business, Incredible Upside
05:18pm, Thursday, 27'th May 2021
Drug Discovery has historically been the most expensive and lengthy step in creating new drugs. SDGR's physics-based software cuts the time in half as well as the costs. Along with being a software co
Schrödinger to Present at Two Investor Healthcare Conferences in June
08:01am, Tuesday, 25'th May 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will present at two investor conferences in June.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:00am, Wednesday, 19'th May 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).
Schrödinger: Under The Radar And Brimming With Potential
08:34am, Tuesday, 18'th May 2021
Schrödinger: Under The Radar And Brimming With Potential
Schrödinger, Inc.'s (SDGR) CEO Ramy Farid on Q1 2021 Results - Earnings Call Transcript
12:54pm, Tuesday, 11'th May 2021
Schrödinger, Inc.'s (SDGR) CEO Ramy Farid on Q1 2021 Results - Earnings Call Transcript
Schrodinger, Inc. (SDGR) Reports Break-Even Earnings for Q1
09:01am, Tuesday, 11'th May 2021
Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of 100.00% and 10.02%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Schrodinger Q1 Earnings
07:16am, Tuesday, 11'th May 2021
Shares of Schrodinger (NASDAQ:SDGR) decreased 1.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 100.00% over the past year to $0.00, whic
